|
市場調查報告書
給藥技術市場：植入・注射・免打針・給藥系統
Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems
|
給藥技術市場：植入・注射・免打針・給藥系統 是由出版商Kalorama Information在2009年09月所出版的。
這份英文市場調查報告書包含110 pages 價格從美金2995起跳。
本報告書內容包括：免打針・給藥系統等注射型、植入（移植）型給藥系統概要、市場現況及2013年之前的市場規模預測、開發中的新產品動向等。內容綱要摘記如下：
第1章 實施概要
第2章 介紹
第3章 動向及發展
- 植入・注射型給藥技術市場的刺激因素
- 筆型注射器
- 產品開發
- 給藥系統動向
- 治療動向
- 技術利用
- 奈米科技
- 給藥技術發展
第4章 市場規模及成長
第5章 競爭動向及市場分析
第6章 企業介紹
- Alkermes, Inc.
- ALZA Corp.
- antares Pharma, Inc.
- Bioject Medical Technologies, Inc.
- CyDex, Inc.
- MGI Pharma, Inc.
- Nektar Therapeutics
- Pacira Pharmaceuticals, Inc.
- pSivida
- SurModics, Inc.
- Zogenix Corporation
- AP Pharma
- Baxter BioPharma Solutions
- QLT USA, Inc.
- Ypsomed Holding AG
附錄
圖表
Abstract
With pharmaceutical companies increasingly looking for ways to extend the
revenue-earning lifetime of their biggest products, drug delivery has become
an important focus of the industry. Kalorama' s Drug Delivery Markets:
Implantable / Injectable and Needle-Free Delivery Systems provides detail for
business planners on the market for implantable / injectable delivery system
markets.
Biopharmaceutical products are driving growth of needle-free systems; there
will likely be significant increases in revenues in the vaccine arena. This
report looks at that trend and reports current and forecasted revenues for the
implantable/injectable drug delivery market, segmented into two main
categories:
- Needle-free drug delivery
- Other Injectable/Implantable
Kalorama' s unique analysis offers segmentation of this market for:
- Drug Delivery Techology Revenues
- Pharmaceuticals Sold via Delivery Technology
This breakout makes the report relevant to business plans of either device
technology companies or pharmaceutical concerns. (This market analysis does
not include drug-eluding stents or prefilled or regular syringes. Kalorama
considers these seperate markets)
The report covers both pharmaceuticals sold through implantable/injectable
delivery systems and the technologies themselves including:
- Detailed Profiles of Key Companies in Implantable/Injectable Delivery
- Brief Round-Up of Smaller Players
- Current Market Size and Forecasts to 2013
- Needle-Free Cost Savings, Protein-Coated Microcrystal Technology,
Nanotechnology, and Other Trends and Developments
- Revenue Forecasts
- New Products in Development
Kalorama' s trusted information-gathering process provides most accurate study
of the implantable/injectable delivery drug market available today.
Information and analysis presented in this report is based on extensive
interviews with senior management of top companies in the industry. While
major research literature and government information is culled, information is
corroborated and key market insights originate from interviews with industry
leaders.
Companies Profiled in the report include:
- Alkermes, Inc.
- ALZA Corp.
- Antares Pharma, Inc.
- Bioject Medical Technologies, Inc.
- CyDex, Inc.
- MGI Pharma, Inc
- Nektar Therapeutics
- Pacira Pharmaceuticals, Inc.
- pSivida
- SurModics, Inc
- Zogenix Corporation
- AP Pharma
- Baxter BioPharma Solutions
- QLT USA, Inc
- Ypsomed Holding AG
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
- Market Drivers
- Market Size and Growth
- Total Implantable/Injectable Drug Delivery Marke
- The Implantable/Injectable Drug Delivery Only Market
- Competitor and Market Analysis
CHAPTER TWO: INTRODUCTION
- Scope and Methodology
- Reasons for Injectable/Implantable Drug Delivery Systems
- History of Injectable/Implantable Drug Delivery
- Phases of Drug Action
- Needle-Free Drug Delivery
- Auto-injectors
- Pen Injectors
- Major Applications
- Safety Concerns
- Products
- Implantable Drug Delivery
- Mechanisms
- Applications
- Products
- Sustained-Release Drug Delivery
- Products
- Targeted Injection Drug Delivery
- Products
- Lipsome
- Niosome
- Microspheres and Nanoparticles
- Cyclodetrins
- Prodrug
- Polymeric Micelles
- PEGylation
CHAPTER THREE: TRENDS AND DEVELOPMENTS
- Drivers of the Implantable/Injectable Drug Delivery Market
- Pen Injectors
- Proprietary Product Development
- Delivery Systems Placement Trends
- Therapeutic Trends
- Incorporation of Technology
- Nanotechnology
- Drug Delivery Development
- Microsphere Technology
- Targeted Technology
- MicroChip Technology
- Protein-Coated Microcrystal Technology
- Needle-Free Delivery Development
- Selected Products in Development
CHAPTER FOUR: MARKET SIZE AND GROWTH
- The Total Implantable/Injectable Drug Delivery Market
- Injectable/Implantable Delivery Technology Only Market
CHAPTER FIVE: COMPETITIVE AND MARKET ANALYSIS
- Competitive Landscape
- Market Analysis
CHAPTER SIX: COMPANY PROFILES
- Alkermes, Inc.
- ALZA Corp.
- Antares Pharma, Inc.
- Bioject Medical Technologies, Inc.
- CyDex, Inc.
- MGI Pharma, Inc
- Nektar Therapeutics
- Pacira Pharmaceuticals, Inc.
- pSivida
- SurModics, Inc
- Zogenix Corporation
- COMPANIES IN BRIEF
- AP Pharma
- Baxter BioPharma Solutions
- QLT USA, Inc
- Ypsomed Holding AG
- APPENDIX: COMPANY DIRECTORY
TABLE OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Figure 1-1 The Worldwide Market for Implantable/Injectable Drug Delivery
Technology and Pharmaceuticals 2003-201
CHAPTER TWO: INTRODUCTION
- Table 2-1 Sequence of Drug Action
- Table 2-2 Marketed Products Using Liposomal Drug Delivery
- Table 2-3 Marketed Products Using Nanoparticle Drug Delivery
CHAPTER THREE: TRENDS AND DEVELOPMENTS
- Table 3-1 Select Products in Development by Drug Delivery Companies
CHAPTER FOUR: MARKET SIZE AND GROWTH
- Table 4-1 The Worldwide Market for Implantable/Injectable Drug Delivery
Technology and Pharmaceuticals 2003-2013
- Figure 4-1 The Worldwide Market for Implantable/Injectable Drug Delivery
Technology and Pharmaceuticals 2003-2013
- Table 4-2 The Worldwide Market for Pharmaceuticals Utilizing
Injectable/Implantable Drug Delivery by Type 2003-2013
- Figure 4-2 The Worldwide Market for Pharmaceuticals Utilizing
Injectable/Implantable Drug Delivery by Type 2003-2013
- Table 4-3 The Worldwide Market for Pharmaceuticals Utilizing
Injectable/Implantable Drug Delivery Market Share by Type 2003-2013
- Figure 4-3 The Worldwide Market for Pharmaceuticals Utilizing
Injectable/Implantable Drug Delivery Market Share by Type 2008
- Figure 4-4 The Worldwide Market for Pharmaceuticals Utilizing
Injectable/Implantable Drug Delivery Market Share by Type 2013
- Table 4-4 The Worldwide Market for Injectable/Implantable Drug Delivery
Systems by Pharmaceutical and Drug Delivery Component 2003-2013
- Table 4-5 The Worldwide Market for Injectable/Implantable Drug Delivery
Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component
2003-2013
- Figure 4-5 The Worldwide Market for Injectable/Implantable Drug Delivery
Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component
2008
- Figure 4-6 The Worldwide Market for Injectable/Implantable Drug Delivery
Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component
2013
CHAPTER FIVE: COMPETITIVE AND MARKET ANALYSIS
- Table 5-1 Leading Suppliers of Implantable/Injectable Drug Delivery
Technology
- Figure 5-1 Cost per Million Injections by Injector Type
|
